Health Care reform means more scrutiny by the government to detect and prevent what it considers fraud and abuse of government payment programs like Medicare and Medicaid.
Compliance programs will likely become mandatory for all providers who do business with the government. From the government’s perspective, that means “effective” programs, and, if fraud or abuse occurs, the company’s leadership and compliance officer will be held accountable.
This session will explain what defines an effective compliance program from the government’s perspective, how your company’s leadership can determine if your program is effective, and what can happen if the government deems your program not effective.
Join Washington G-2 Reports and our expert faculty Tuesday, February 2nd at 2PM ET and you will be able to:
- Identify the criteria the government will use to determine if a compliance program is effective or not
- Assess your company’s program through the use of an audit checklist to determine if it meets the requirements for effectiveness
- Understand the consequences of not having an effective compliance program in the event of a government audit or investigation
You’ll also have the opportunity to ask questions in the interactive Q&A portion of the program. Take this hassle-free approach to gain insight into this critical issue in the laboratory industry. And you can invite your entire group – for one low fee.
Register today for $295. Washington G-2 subscribers pay only $265. Unable to attend? Order the CD today!
FEATURED FACULTY
Christopher Young
President, Laboratory Management Support Services
Hope Foster, Esq.,
Mintz Levin Cohn Ferris Glovsky and Popeo
HOST & MODERATOR:
Kimberly Scott
Senior Editor, Washington G-2 Reports
Washington G-2 Reports is approved as a provider of PACE contact hour credits for clinical laboratory professionals, including Florida or California licensees, by the American Society for Clinical Laboratory Science (ASCLS). This program qualifies for 1.5 CEU credit hours.
